Patents by Inventor Patrícia Moura Da Rosa Zimmerman

Patrícia Moura Da Rosa Zimmerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition, excipient for the composition and use of the composition
    Patent number: 11389423
    Abstract: A pharmaceutical composition containing synthetic Cannabidiol and its use in obtaining a medication for the treatment of neurological disorders, as well as the main excipients used in the production process, in addition to its small, medium, and large-scale preparation process. The use of the composition for the treatment of neurological disorders in human or animal populations, in particular in the treatment of Parkinson's disease, in the range of 300 to 850 mg/day or at daily doses of 100 to 1750 mg for neuroprotective action.
    Type: Grant
    Filed: February 11, 2019
    Date of Patent: July 19, 2022
    Assignees: Prati, Donaduzzi & Cia Ltda, Universidade De São Paulo
    Inventors: Luiz Donaduzzi, Carmen Maria Donaduzzi, Liberato Brum Junior, Patricia Moura Da Rosa Zimmerman, Emanuelle Webler, Leticia Mello Rechia, José Alexandre Crippa, Jaime Eduardo Cecilio Hallak, Antonio Waldo Zuardi, Francisco Silveira Guimarães, Alline Cristina De Campos, Vitor Tumas, Elaine Aparecida Del Bel Belluz Guimarães
  • PHARMACEUTICAL COMPOSITION, EXCIPIENT FOR THE COMPOSITION AND USE OF THE COMPOSITION
    Publication number: 20200368197
    Abstract: A pharmaceutical composition containing synthetic Cannabidiol and its use in obtaining a medication for the treatment of neurological disorders, as well as the main excipients used in the production process, in addition to its small, medium, and large-scale preparation process. The use of the composition for the treatment of neurological disorders in human or animal populations, in particular in the treatment of Parkinson's disease, in the range of 300 to 850 mg/day or at daily doses of 100 to 1750 mg for neuroprotective action.
    Type: Application
    Filed: February 11, 2019
    Publication date: November 26, 2020
    Applicants: Prati, Donaduzzi & Cia Ltda, Universidade De São Paulo
    Inventors: Luiz Donaduzzi, Carmen Maria Donaduzzi, Liberato Brum Junior, Patrícia Moura Da Rosa Zimmerman, Emanuelle Webler, Letícia Mello Rechia, José Alexandre Crippa, Jaime Eduardo Cecilio Hallak, Antonio Waldo Zuardi, Francisco Silveira Guimarães, Alline Cristina De Campos, Vitor Tumas, Elaine Aparecida Del Bel Belluz Guimarães